Nanoclay-reinforced HA/alginate scaffolds as cell carriers and SDF-1 delivery-platforms for bone tissue engineering
View/ Open
Date
2022-07-25Author
Erezuma Aldamiz-Etxebarria, Itsasne
Lukin Garmendia, Izeia
Pimenta-Lopes, Carolina
Ventura, Francesc
Garcia-Garcia, Patricia
Reyes, Ricardo
Arnau, Mª Rosa
Delgado, Araceli
Taebnia, Nayere
Kadumudi, Firoz Babu
Orive Arroyo, Gorka
Metadata
Show full item record
International Journal of Pharmaceutics 623 : (2022) // Article ID 121895
Abstract
Bone tissue engineering has come on the scene to overcome the difficulties of the current treatment strategies. By combining biomaterials, active agents and growth factors, cells and nanomaterials, tissue engineering makes it possible to create new structures that enhance bone regeneration. Herein, hyaluronic acid and alginate were used to create biologically active hydrogels, and montmorillonite nanoclay was used to reinforce and stabilize them. The developed scaffolds were found to be biocompatible and osteogenic with mMSCs in vitro, especially those reinforced with the nanoclay, and allowed mineralization even in the absence of differentiation media. Moreover, an in vivo investigation was performed to establish the potential of the hydrogels to mend bone and act as cell-carriers and delivery platforms for SDF-1. Scaffolds embedded with SDF-1 exhibited the highest percentages of bone regeneration as well as of angiogenesis, which confirms the suitability of the scaffolds for bone. Although there are a number of obstacles to triumph over, these bioengineered structures showed potential as future bone regeneration treatments.